FDA approves first gene therapy for genetic hearing loss
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The drugmaker said it will offer the drug for free to U.S. patients. Otarmeni is approved to treat a very rare form … Read more